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Io<erleukin- I (IL- I) is a family of polypeptides that media tes 
a wide range of in.f1ammatory and immune responses. In 
human skin, unstimulated keratinocytes produce a large 
amount of such cytokines. Although the precise role of IL-l 
in the skin is unknown. there is experimenraJ evidence sup-
porting involvement of IL-l in the pathogenesis of inflam-
matory skin diseases. In this study, we investigated the in situ 
localization ofIL-I alpha and IL- I beta in normal and psoria-
tic skin. Using polydona.1 antibodies an.d the avidin-biocin 
peroxidase complex, we demonstrated the presence of borh 
IL-l alpha and IL-l beta in normal and psoriatic formaLin-
W ithin the last decade a large amounrof d inical and e'Xperimental evidence has accumulated supporting the hypothesis that incerleukin-l (Il-1) plays an importanc role in inflamma-tory lnd immune responses [1,21. IL-l was 
originally defined by its ability (Q enhance lymphocyte proliferation 
and, later. by possession of a number of biologic activities, incl uding 
induction of the acuce- phase response and systemic growth and 
diffe.rentiation signals for immune ceBs t' ,2). lL-1 is a potent neu-
trophil and T-cell chemoatcTactant 11 ,3J and has the abiliry to in-
duce mu.rine epidermal hyperplasia and subcutaneous fibrosis in 
vivo 14J.The cloning of two distinct fo rms of IL-1. alpha and bera. 
has permitted confirmation of these biologic properties. Both forms 
of fL.-l share: little amino acid homology and have the same spec-
tnun of biologic activities [5,6], presumably media ted by binding to 
the same. receptor 171. 
Although ph.agocytic cells are the main SOurce ofIL-l [1,2J. ocher 
cellular rypes also produce this cytokine. In the human epidermis. 
both Langerhans cells and keratinocytes have been shown to pro-
duce an epidermal cell-derived thymocyte activating facror (ETAF) 
[8 - 11 J with biochemical and biologic properties identical to those 
of human macrophage/ monocyte-derived IL-l /11 ,12J. Whether 
ETAf 1S structurally identical to monocyte IL-l has not been en-
tirely resolved [13J. Unstimulated keratinocytes produce predomi-
nantly IL- t alpha and smaller amou.nt of Il-l beta as identi fied on 
Northern blots [11 ]. Similar results have been found in murine 
epidermis by in situ hybridization, suggesting that Il-l alpha is the 
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fixed paraffin-embedded tissues. III both cases, IL-I alpha was 
more prominent. However, the distribution of IL-l alpha 
differed betv../een normal and psoriatic skin. In nonnaJ skin, 
IL-l alpha distribution was predominantly interceUular, 
whereas IL-l alpha dis tribution was predominandy within 
the cytoplasm in psoriatic skin. These studies confirm that 
IL-I alpha is the predominant form of IL-I in the skin and 
provide further support for the hypothesis that IL-I partici-
pates in [he pathogenesis of psoriasis. ) b west Derma/oj 
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dominanr species of llpl in skin {14j. IL- 1 acriviry may also be 
detected in high amounts in stra.tum corneum and in cultured 
human epidermal cells [15.16]' However, rhe subcellular site of 
IL- l production in epidermal cells has not been identified. 
fL- J acts in an aurocrine manner to stimulate epidermal growth as 
demonstrated by stimulation of keratinocyte proliferation and 
DNA synthesis in cultures 117,18]. Because of r.hese autocrine ef-
fects as well as IL-l actions on neutrophi ls. a role for fL-l in psoria-
sis has been sought 119,20j. Recent srudicS" have used immunostain-
ing and bioassays to detect fl-J in psoriatic plaques and scales 
[20.21J. We have asked whether lL-l alpha and IL-l beta can be 
detected in psoriatic skin. OUI studies establish an alterared distrihu-
tion of Il-t alpha and Il-t beta in psoriatic skin and support the 
hypothesis dlat IL-I is involved in the pathogenesis of psoriasis. 
MATERIALS AND METHODS 
Preparatioo ofSpecimeos Twelve fonnalin-fixed paraffin-em-
bedded biopsies from patients with clinical and histopathologic fea-
tures consistent with psoriasis were obtained from the Pathology 
Department at rhe New England Medical Center Hospital (Table 
I). T ..... elve nonnal S"k.in samples were received from the Dermatolo-
gic Surgery Departmenr from pacients undergoing plastic recon-
structive surgery. These tissues were fixed in formalin as above and 
used as a control skin. 
Antibodies Anti-human Il-l alpha and anti-human IL-l bera 
rabbit polyclonal antibodies (lgG) raised agains t recombinant 
human II..,.. 1 alpha and beta, respectively, were produced and kindly 
provided by Dr. C.A. Dinarello. Rabbits were imm.unized with 
multiple intradermal injections in complete Freund's adjuvant. 
After 6 weeks, rabbits received four weekly i.m. injections in in-
complete Freund's adjuvant and four weekly i.v. injections. Rabbits 
were bled, and seria l dilutions of 40% ammonium sulfate precipi-
tated globulin preparations were shown to have a neutralizing dfect 
on the respective forms of IL-l over a wide concentration range. 
They did not cross-react as detennined by spectrophotometric anal-
ysis (221. Tbese :mribodies were employed as the primary antibody 
at an optimal concentration of 2,ug/ ml. 
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Table I. Patients with Psoriasis 
Patienr- Ago Sox C linical Classi fi c:uion of Psonasi.o; 
1 66 F Pustular psori2sis 
2 40 F Psoriasis vu.lgaris 
3 33 M Psoriasis vulgaris 
4 37 M Psoriasis vulgaris 
5 33 F Psoriasis vulgaris 
6 9 F Psoriasis vulgaris 
7 27 M P~ori25is vulgaris 
8 49 F Psoriasis vulgaris 
9 59 F Psoriasis vulgaris 
10 73 F Psoriasis vulgaris 
11 43 M Psoriasis vulgaris 
12 3 M Psori.asis vulgaris 
• BLO!,SLt:'S for conhrnutLIm of the climc.al diagnosis of p~oriasi s were oblained fmm 
tlu:.sc: pal lenl.s allhe New EngJalldMediGlJ Center H osplal. All cham. wererevi('w(d to 
confirm th:n p~ueJlts had both clinical ~nd histologic features of psorlasLS, 
Cytochemical Visualization of Skin Tissue The avidin-biotin 
peroxidase technique was used for derection ofIL-1. The ABC kit 
from Vectastain la boratories [23,24J was used as an Jimmunoenzy-
matie technique. Briefly , 6-Jim sections of the rissues were CUl and 
placed on gelatin coared slides. deparaffined by xylene, and re hy-
drated r.hrough graduated echanol solutions. The endogenous per-
oxidase was blocked with 0.9% hydrogen peroxide in phosphare 
buffered saline (PBS. pH 7.2) for 30 min at room temperature. 
After wash ing rwicr' with buffer, the tissue sections were incubared 
with 1 % normal goat serum in PBS for 60 min to avoid nonspecific 
binding. The excess solu tion was removed and the sections were 
incubatcd with l : 100 or 1. ; 1000 dilutions of anti-human lL-l 
alpha or anti-human IL-l bera for 60 min. The slides were rhen 
washed twice wirh PBS 0.1 % BSA and incubated wirh a biotiny-
Iated goar anti-rabbit IgG for 45 min. Aftet further washing, the 
rissue sections were' incubated wjrh the- avidin-biotin-peroxidase 
complex for 30 min and washed with buffer. The specific subsrrace 
(1 mg/ rnl diaminobenzidine terrahydrochloride in 0. 1 MITis 
buffer plus 0.01 % hydrogen peroxide in distilled water) was added 
for 5 min. Finally. tbe sections were washed wirh tap water for 
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5 min , counrerstained with methyl green, coversl ipped with Aqua-
mount, and examined under light microscope. An irrelevant rabbi r 
IgG was included in each assay and used as a control. All of rhe 
incubations in the av idi n- biotin-peroxidase technique were done in 
a moist chamber at room remperarure, 
Blocking Studies In order ro [esr [he specificiry of the reaction, 
serial dilurions of rhe recombinant It-I alpha and 1[....1 beta were 
prf'-mixed with 2.5 J1g/mland 5 J1.g/ml of anri- IL-1 alpha and anti-
lL-I beta, respectively. Preincubation with a combination of 5 Jig/ 
ml of anti It-I beta w irh serial dil utions of recombinant IL-I alpha 
was done in order to evaluate cross-reactiviry. This mixture was lefr 
oVf'rnight at 4°c before being added to rhe r.iS5ues. The antibodies 
mixed with PBS were used as a positive comro1. 
RESULTS 
Cytochemical Visualization of Tissue lL~l W e used a three-
Hep avidin-biotin-peroxidase technique in order {Q determine 
whether IL-l alpha and/ or 1[",,1 beta could be detected within nor-
mal human epidermis. There were rwo different but non-exclusive 
parrcrns of cellular localizarion of IL-l for borh It.- t alpha and It.-I 
beta (Fig 1). In many specimens, staining was most apparent around 
[he cell membrane and is defined as intercellular. In other speci-
mens, IL-l appeared within rhe cytoplasm and is defined as a intra-
cellular cytoplasmic dis[,ribucion. indirect immunofluorescence 
using rhe same ami body dilmions also confirmed our observations, 
However, rhis recllllique was less sensitive in detecting It.-I. 
In normal skin, both IL-l alpha and IL-l beta WeTe present in all 
samples from the twelve nonnal ind ividuals. with prominent reac-
riviry for 1[.... 1 alpha (Fig l A, 8). The strongest antibody react ion 
was localized to the srrarum corneum, and a lesser amount was 
detected in (he squamous layer. In nine of our normal specimens. 
the pattern was predominantly intercellular (Fig lA) , while three 
specimens demonstrated both imraceJlular cytoplasmic and inrer-
cellular localization (T able II). In three cases immunoreactive 1[",,1 
was presem within the basal cell layer. 
IL-l Alpha and IL-t Beta in Psoriatic Skin As in the normaJ 
individuals, the skin from patients with psoriasis stained positively 
for IL-l alpha and/or IL-l beta. with more intense staining for It-I 
Figure 1. lnununoenzymatic localization oflL- J alpha (A) and IL- l beta (B) in normal skin. Two patterns of srainingare present: t. an interceUular pattern 
with strong reactivity around the cell membrane and 2. a cytoplasmic partern which is less prominent. IL-l alpha is dearly present in the stratum corneum. 
Some interce llular immunoreactivity for l"L-l beta (B, arrow) is also present. The IL-l beta immunosraining is not greatly above the background as compared 
with the reactivity of the irrelevant rabbit 19G u.~ed as control (C) (1200X). 
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Table U. Distribution Panerns of l L.l in Normal and Psoriatic Skin· 
Number of Cytoplasmic 
T issue Spc:cimeru Intercel lular Only Distributio n Only Both POIttc rns NegOitive 
ImmunOfeaC"tive IL-l alpha 
Nomlal 12 9 0 3 0 
Psoriaric 12 0 0 12 0 
Immunoreactive IL.-l bc[;l. 
Norm:!] 12 12 0 0 0 
Psoriatic 12 0 0 10 2 
• Dlffercnl dlunbl.ll1on paut'rIIs of 11..-1 alpha and H..-I btu in nOffllll ;md p~oriaric umplcs dt'lcclnt by lilt' aVldin-hlonn-pero)ilalM' ft'chr). lqUt'. as QcscnlK-d 10 M<lIVl;JIs lind 
Aft/hoJl. Only re-sul[J: t'mploymg 1/ 100 dilution of ;lIl1100aY ,ue- dispbyrd. The: p.llterns lft' lJ, Illunr.llrd in Figs I alia 2. 
alpha (Fig 2A, B) . However, in coorrasr to normal skin. IL- l was 
consisrendy presen t with intense staining both in the squamous 
layer and basal cell layer. Though some specimens (six of 12) dem-
onstrated JL-I alpha and fL-1 ~ta in the str'3tum corneum. the 
scaining was less intense. suggesting decreased amounts of immuno-
reactive IL-I alpha and fL-1 beta in psoriatic sttatum corneum. h 
should be noted that although the magnification is the same for 
both normal and psoriatic Skill. the increased ~ize of the psoriatic 
kcra tinocyres make rhem appear la rger 125J. Similarly. the marked 
ac:mthosis make it impossib le to visualize all layers o f the epidennis 
in the same hjgh~power microscopic field. Thus, thc photomicro-
graphs are equivalent. 
The cellular distribution of IL-t alpha and IL-t beta also differed 
in psoriatic skin. All the psoriatic specimens had a prominent intra-
cell ular cytoplasmic pa ttern as well as a intercellular staining (Fig 
2A. B). In cwo cases, no staining was present even at the highet 
concentration of a. mi-IL-1 beta (1/ 100 dilution). T hese twO speci-
mens were negative for this cyrokine in hvO different experiments 
with dupli cate samples (Table 11)', excluding technical reasons as the 
explanation for failure to detect IL- l beta. 
Specific ity C o ntro ls In order to confirm the specificity of the 
reaction. ,m inh ibition assay was developed. Polyclonal IL.-I alpha 
and fl- l bera antibodies were premixed with recombinant IL-l 
alpha and IL~ 1 bet:!, respectively. before incubation with the tissue 
seccions. W e found speci fic inhibition of the reacti vity in a dose-de-
pt'lldenr fashion. No epidermal staining was observed when 5 J1.g/ 
Figure 2. IOlmunoen2ym2tic locaJiution of Ilot alph2 
(A) 2nd IL-l beta (8 ) in psori.:ltic skin. Two pauetos of 
staining 2re prestnt: I. an intercellular pattern w ith weak 
reactivity around theeel l membrane and 2. an intr:lcellular 
c)'roplasmic pattern. which is strongl), reOictive. IL- I beta 
immunostain ing is less intense when compared with IL-l 
alpha: however. if is ciearlydi/ferenr from rhe reactivity of 
th e irrelevant r:abbit IgG used as control (C) (1200X). 
1111 of rl l-1 alpha was preincubated with 2.5,ug/ml of ant i-fL.1 
alpha prior [Q t rea rment of tissues (Fig 3A , B). No immunost.1ining 
was presenr when 80 p:g/ml of rlL. 1 bera was mi.xed with 5 pg/ ml 
of anti-Il- I beta (fig 4A> B) . H owever. this immunoreactivi ry was 
not blocked when the s.ame anti-IL-I beta concentration was prei.n-
cub;tted with serial dilutions of tIL-1 alpha (concentration 80 to 
5 Jlg/ ml) (Table II I). The incub.1tlon of normaJ and psoriatic sam-
ples with the irrdevant rabbit 19C was consistC'ntl y nC' gative. con-
fi rming the speci ficity of the reaction. 
DISCUSSION 
A wide' variery of inflammatory discases are ch ... racte rizcd by infil-
tT3tion of polymorphonuclear and mononuclear cells into the skin. 
HowevC' r, the inducers and modulators of tbese inflammatory pro-
cesses arc nOt well understood. It has been proposed that the kcrati-
nocytes part icipate" in this immune and inflammatory response by 
elaborating a factor ind istinguishabl e biochemically and function-
all y from the macrophage derived Il- l [8 - I2l This cy to kinc can 
be detected in large amounts in stu tum corneum from normal skin 
and has an aurocrinc proliferat ive effect on kera tinocyte cultures 
l15.17 ,18]. Because psoriasis is characteriud by epidermal hype.r-
proliferation and inflammatory cell infiltration. we compared [he 
presence oflL-t in psoriatic and normal skin . 
In order to study in situ localization of lL- l alpha and lL- l beta ill 
epidermis. we used rhe immunoenzymatic avidin-biotin-peroxidase 
technique [23.241. a bigh ly sensitive method to Jocalize antigens in 
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Figure 3. Blockmg s(Ucilcs for IL-I alpha. POSItIVC inullunorcacu\' lry for 
I L-I .Ilph:a IS prestnl III A. llIocklng dfect by prior antlgeu-:antibody :absorp-
tlOII. as dC:K nbed III Matt ria/s (HId Mrthods, is diu5tr.ued by rhe absence: of 
immunost:umng (D) (SOOX). 
formalin fixed tiss ues. This techuiq ue has the advanragc of preserv-
ing cytologic features so that the nature of the positively stained 
cells can be precisely evalua ted. Using lIlonospecific polyclol1al an-
tibodies. we clearly demonstrated both cytoplasmic and intercellu-
lar localizarion of IL-I al pha. The intense IL-l alpha reactivity at 
rhe inrercC'llular border is consistent with the work of Goldminz et 
a1126J . Their studies indicate-d that this cytokine is membrane asso-
ciated, as demonstra ted by significant Il- l acrivity in cell membrane 
preparations derived from human foreskin epidermaJ cultures. Ad-
d.itionally. Oxholm c t al 127) found both intercellular and IL- 1 
cytoplasmic immunos~ining for IL-l in normal skin; howe-ver. 
high conce-ntra tions of antibody were required for deteccion of cy-
toplasmic ll- I. Our studies ofIL-l alpha in normal skin are consist-
ent with these reports because both intercell ular and cytoplasmic 
IL-l alpha wcre detccted. Studies of in situ hybridization in normal 
murine epidermis demonstrating on ly mRNA for IL- l alpha It 4] 
arc also consistent wi th our findings of greater amoun ts of IL- t 
alpha. 
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Figure 4. Blockmg studies for IL-I b.=-ra. This p:l.rticui.u skin section clearly 
dcmonstr:att"s mmlUnoreactiviry for IL-l bela (A). Spe:cific block.ing dfeci bl' :mti~cn·antlbody competition. as dCM:TIbcd in Matt'riau Qnd MelhNis, is 
il ustrarcd by Ih~ ... bscnce of immunosta lning (B) (SOOX). 
Our findings also suggest that IL- I beta is prescnr in low 
amounts. Previous reports did nor distinguish fl. l alpha and IL-l 
hcra hy immullosraining f27J. High concentr.atioru of ancibody 
were required in our stud.ies to detect IL-! beta. Staining was not 
greatly above background. and careful attention to technical detail 
was necessary for reproducibility. If methal10l treatment was omit-
ted. resulting in a higher background. IL-l beta acrivirycould not be 
distillguished. However, the blocking stud ies conhrm the speci fic-
ity of our an tibodies. Previous demonstrations of small amounts of 
mRNA for Il-I beta in normal skin support our findings /11]' An 
additional explanation for differences in our results may be related 
to affinity of the anribodies employed for diftcrenr epiropes of IL-l 
beta. 
Il- I alpha was also the predominam cytokine in psoriatic skin 
samples. However, the principal site was cyroplasmic. ln conrrast to 
the normal skin. at least half of the psoria[ic specimens lack IL-l in 
the- stratulll corneum, yer the squamous layer was consistently posi-
tive, suggesting a rearrangement of the normal partern of cycokine 
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Table ID. Blocking Assays by Amigen-Antibody Absorption 
Illustrate the Specificity of Our Anti-IL-l Alpha and Anti-lL-l 
Beta Antibodies· 
Antibody Recombinant 
Conce ntration Interleukin-I T issue 
"'sfml) "'sfml) ImmwlOreaccivity 
anti~IL- 1 alpha ri L-l alpha 
2.5 5 negative 
2.5 2.5 negl1tivr 
2.5 1.25 negative 
2.5 .6 negative 
2.5 .3 +++ 
Anti-IL- I beta riL-l brrn 
5 80 negative 
5 40 + 
5 28 + 
5 16 ++ 
Anti-IL.I bea rlL- l alpha 
5 80 ++++ 
5 40 +++ 
5 20 ++++ 
5 10 ++++ 
5 5 ++++ 
• The ~ntibody concentn.mm was fixed (as indiated). and dtc~aslllg amountS of 
~nrigen (rIL-l alph:r. or rlL·! beta) we're added. As the :r.ungen eoncentr:r.t lon was 
reduced. tissue suiuing .Ippe:w:d. The imrnl.lllohistochcmical studics were performed as 
d«eribed in MIlIV'illls Ilnd MEthods. No cross-ructh·icy betw('('n 11· 1 ~lpha and bct.il was 
observed. 
localization. Interesting. the squamous layer in psoriasis is mainly 
characterized by incre,sed cellular proliferation and inflammamry 
cells infiltration . processes that can be modulated by It-I. 
Although the biologic relevance of OUT findings are unknown, we 
speculate that the high rate of keratinocyte proliferation and the 
epidermal neutrophil infiltration in psoriasis might be related to in 
situ overproduction of IL-l with subsequent au[ocrine stimulation 
and cel lular recruitment. In order to further delineate [he relation-
ship bcrween IL- l and d.isease activity in psoriasis studies correlating 
the presence of IL-l with disease activity are in progress. 
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